The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Pharmacogenetics of Psychotropic Drug Response
Abstract
OBJECTIVE: Molecular genetic approaches provide a novel method of dissecting the heterogeneity of psychotropic drug response. These pharmacogenetic strategies offer the prospect of identifying biological predictors of psychotropic drug response and could provide the means of determining the molecular substrates of drug efficacy and drug-induced adverse events. METHOD: The authors discuss methods issues in executing pharmacogenetic studies, review the first generation of pharmacogenetic studies of psychotropic drug response, and consider future directions for this rapidly evolving field. RESULTS: Pharmacogenetics has been most commonly used in studies of antipsychotic drug efficacy, antidepressant drug response, and drug-induced adverse effects. Data from antipsychotic drug studies indicate that polymorphisms within the serotonin 2A and dopamine receptor 2 genes may influence drug efficacy in schizophrenia. Moreover, a growing body of data suggests a relationship between the serotonin transporter gene and clinical effects of the selective serotonin reuptake inhibitors used to treat depression. A significant relationship between genetic variation in the cytochrome P450 system and drug-induced adverse effects may exist for certain medications. Finally, a number of independent studies point to a significant effect of a dopamine D(3) receptor polymorphism on susceptibility to tardive dyskinesia. CONCLUSIONS: Initial research into the pharmacogenetics of psychotropic drug response suggests that specific genes may influence phenotypes associated with psychotropic drug administration. These results remain preliminary and will require further replication and validation. New developments in molecular biology, human genomic information, statistical methods, and bioinformatics are ongoing and could pave the way for the next generation of pharmacogenetic studies in psychiatry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
Genomic Control for Association Studies
Devlin, B., & Roeder, K. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00997.x · Cited by 3,162
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Van Tol, H. H. M., Bunzow, J. R., Guan, H.-C., Sunahara, R. K., Seeman, P., Niznik, H. B., & Civelli, O. (1991) · Nature · doi:10.1038/350610a0 · Cited by 2,014
Characterization of single-nucleotide polymorphisms in coding regions of human genes
Cargill, M., Altshuler, D., Ireland, J., Sklar, P., Ardlie, K., Patil, N., Lane, C. R., Lim, E. P., Kalyanaraman, N., Nemesh, J., et al. (1999) · Nature Genetics · doi:10.1038/10290 · Cited by 1,547
Use of Unlinked Genetic Markers to Detect Population Stratification in Association Studies
Pritchard, J. K., & Rosenberg, N. A. (1999) · The American Journal of Human Genetics · doi:10.1086/302449 · Cited by 1,198
Kapur, S., & Seeman, P. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.360 · Cited by 1,140
The Genetic Basis of Complex Human Behaviors
Plomin, R., Owen, M. J., & McGuffin, P. (1994) · Science · doi:10.1126/science.8209254 · Cited by 1,019
Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences Clinical Psychiatry
Kaplan, H. I., Sadock, B. J., & Sadock, V. A. (1994) · Cited by 996
Sachse, C., Brockmöller, J., Bauer, S., & Roots, I. (1997) · Europe PMC (PubMed Central) · Cited by 973
Multiple dopamine D4 receptor variants in the human population
Tol, H. H. M. V., Wu, C. M., Guan, H.-C., Ohara, K., Bunzow, J. R., Civelli, O., Kennedy, J., Seeman, P., Niznik, H. B., & Jovanovic, V. (1992) · Nature · doi:10.1038/358149a0 · Cited by 955
Self-citationThe TDT and other family-based tests for linkage disequilibrium and association.
(1996) · PubMed Central · Cited by 901
Haplotype Variation and Linkage Disequilibrium in 313 Human Genes
Stephens, J. C., Schneider, J. A., Tanguay, D. A., Choi, J., Acharya, T., Stanley, S. E., Jiang, R., Messer, C. J., Chew, A., Han, J.-H., et al. (2001) · Science · doi:10.1126/science.1059431 · Cited by 873
Schizophrenia genesis: the origins of madness
(1991) · Choice Reviews Online · doi:10.5860/choice.28-6500 · Cited by 832
Johansson, I., Lundqvist, E., Bertilsson, L., Dahl, M. L., Sjöqvist, F., & Ingelman-Sundberg, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11825 · Cited by 644
Smeraldi, E., Zanardi, R., Benedetti, F., Bella, D. D., Perez, J., & Catalano, M. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000425 · Cited by 614
Molecular genetics of CYP2D6: Clinical relevance with focus on psychotropic drugs
Bertilsson, L., Dahl, M., Dalén, P., & Al‐Shurbaji, A. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01548.x · Cited by 579
Greenberg, B. D., Tolliver, T. J., Huang, S.-J., Li, Q., Bengel, D., & Murphy, D. L. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990205)88:1<83::aid-ajmg15>3.0.co;2-0 · Cited by 533
Small, K. M., Wagoner, L. E., Levin, A. M., Kardia, S. L. R., & Liggett, S. B. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020803 · Cited by 530
Novel antipsychotics: comparison of weight gain liabilities.
Wirshing, D. A., Wirshing, W. C., Kysar, L., Berisford, M. A., Goldstein, D., Pashdag, J., Mintz, J., & Marder, S. R. (1999) · PubMed · Cited by 523
Molecular Targets of Lithium Action
Phiel, C. J., & Klein, P. S. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.789 · Cited by 515
Newer antidepressants and the cytochrome P450 system
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.311 · Cited by 482
Seeman, P. (1992) · PubMed · Cited by 439
Kirchheiner, J., Brøsen, K., Dahl, M. L., Gram, L. F., Kasper, S., Roots, I., Sjöqvist, F., Spina, E., & Brockmöller, J. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00299.x · Cited by 422
Pollock, B. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00132-9 · Cited by 415
Association of antipsychotic druginduced weight gain with a 5-HT2C receptor gene polymorphism
Reynolds, G. P., Zhang, Z.-J., & Zhang, X.-B. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08913-4 · Cited by 412
High-Throughput Genotyping with Single Nucleotide Polymorphisms
Ranade, K., Chang, M.-S., Ting, C.-T., Pei, D., Hsiao, C.-F., Olivier, M., Pesich, R., Hebert, J., Chen, Y.-D. I., Dzau, V. J., et al. (2001) · Genome Research · doi:10.1101/gr.157801 · Cited by 398
Serotonin transporter gene polymorphism and antidepressant response
Kim, D. K., Lim, S.-W., Lee, S., Sohn, S. E., Kim, S., Hahn, C. G., & Carroll, B. J. (2000) · NeuroReport · doi:10.1097/00001756-200001170-00042 · Cited by 398
Novel Antipsychotics: Comparison of Weight Gain Liabilities
Wirshing, D. A., Wirshing, W. C., Kysar, L., Berisford, M. A., Goldstein, D., Pashdag, J., Mintz, J., & Marder, S. R. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0602 · Cited by 393
Marez, D., Legrand, M., Sabbagh, N., Lo Guidice, J.-M., Spire, C., Lafitte, J.-J., Meyer, U. A., & Broly, F. (1997) · Pharmacogenetics · doi:10.1097/00008571-199706000-00004 · Cited by 380
Risch, N., & Teng, J. (1998) · Genome Research · doi:10.1101/gr.8.12.1273 · Cited by 366
Pharmacogenetic prediction of clozapine response
Arranz, M., Munro, J., Birkett, J., Bolonna, A., Mancama, D., Sodhi, M., Lesch, K., Meyer, J., Sham, P., Collier, D., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02221-2 · Cited by 347
Bymaster, F. P., Zhang, W., Carter, P. A., Shaw, J., Chernet, E., Phebus, L., Wong, D. T., & Perry, K. W. (2002) · Psychopharmacology · doi:10.1007/s00213-001-0986-x · Cited by 334
Association between clozapine response and allelic variation in 5-HT2A receptor gene
Arranz, M. J., Collier, D. A., Sodhi, M., Ball, D., Roberts, G. W., Sham, P., Kerwin, R., Price, J., & Roberts, G. W. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92168-0 · Cited by 333
Clinical Pharmacokinetics of Mirtazapine
Timmer, C. J., Ad Sitsen, J. M., & Delbressine, L. P. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200038060-00001 · Cited by 319
Common allelic variants of cytochrome P4503A4 and their prevalence in different populations
Lamba, J. K., Lin, Y. S., Thummel, K., Daly, A., Watkins, P. B., Strom, S., Zhang, J., & Schuetz, E. G. (2002) · Pharmacogenetics · doi:10.1097/00008571-200203000-00006 · Cited by 316
Zanardi, R., Benedetti, F., Di Bella, D., Catalano, M., & Smeraldi, E. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200002000-00021 · Cited by 308
10-hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genes*
Dalén, P., Dahl, M.-L., Ruiz, M. L. B., Nordin, J., & Bertilsson, L. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90040-6 · Cited by 285
Pharmacogenetics of Antidepressant Medication Intolerance
Murphy, G. M., Kremer, C., Rodrigues, H. E., & Schatzberg, A. F. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.10.1830 · Cited by 283
Self-citationStahl, S. M. (1998) · PubMed · Cited by 256
Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response
Arranz, M. J., Munro, J., Sham, P., Kirov, G., Murray, R. M., Collier, D. A., & Kerwin, R. W. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00032-2 · Cited by 255
Clozapine-induced weight gain: prevalence and clinical relevance
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.1.68 · Cited by 248
Pickar, D., Labarca, R., Linnoila, M., Roy, A., Hommer, D., Everett, D., & Paul, S. M. (1984) · Science · doi:10.1126/science.6474162 · Cited by 246
Lerer, B. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00293-2 · Cited by 241
Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients
Steen, V. M., Løvlie, R., MacEwan, T., & McCreadie, R. G. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000249 · Cited by 239
Lundstrom, K., & Turpin, M. P. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1296 · Cited by 232
Chou, W. H., Yan, F.-X., de Leon, J., Barnhill, J., Rogers, T., Cronin, M., Pho, M., Xiao, V., Ryder, T. B., Liu, W. W., et al. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200004000-00019 · Cited by 226
Yoshida, K., Ito, K., Sato, K., Takahashi, H., Kamata, M., Higuchi, H., Shimizu, T., Itoh, K., Inoue, K., Tezuka, T., et al. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00287-1 · Cited by 226
Arranz, M. J., Munro, J., Owen, M. J., Spurlock, G., Sham, P. C., Zhao, J., Kirov, G., Collier, D. A., & Kerwin, R. W. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000348 · Cited by 220
Racial Disparities in Antipsychotic Prescription Patterns for Patients With Schizophrenia
Kuno, E., & Rothbard, A. B. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.4.567 · Cited by 220
Yuan, X., Yamada, K., Ishiyama-Shigemoto, S., Koyama, W., & Nonaka, K. (2000) · Diabetologia · doi:10.1007/s001250050056 · Cited by 219
Basile, V. S., Masellis, M., McIntyre, R. S., Meltzer, H. Y., Lieberman, J. A., & Kennedy, J. L. (2001) · PubMed · Cited by 211
Self-citationThe relationship between paroxetine and the sparteine oxidation polymorphism
Sindrup, S. H., Brøsen, K., Gram, L. F., Hallas, J., Skjelbo, E., Allen, A., Allen, G. D., Cooper, S. M., Mellows, G., Tasker, T. C. G., et al. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.23 · Cited by 205
Kramer, M. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830180085011 · Cited by 199
Zill, P., Baghai, T. C., Zwanzger, P., Schüle, C., Minov, C., Riedel, M., Neumeier, K., Rupprecht, R., & Bondy, B. (2000) · NeuroReport · doi:10.1097/00001756-200006260-00018 · Cited by 197
Raimundo, S., Fischer, J., Eichelbaum, M., Griese, E.-U., Schwab, M., & Zanger, U. M. (2000) · Pharmacogenetics · doi:10.1097/00008571-200010000-00001 · Cited by 189
Minov, C., Baghai, T. C., Schüle, C., Zwanzger, P., Schwarz, M. J., Zill, P., Rupprecht, R., & Bondy, B. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01704-9 · Cited by 189
Association between clozapine response and allelic variation in the 5-HT2C receptor gene
Sodhi, M. S., Arranz, M. J., Curtis, D., Ball, D. M., Sham, P., Roberts, G. W., Price, J., Collier, D. A., & Kerwin, R. W. (1995) · NeuroReport · doi:10.1097/00001756-199512000-00041 · Cited by 188
Gejman, P. V. (1994) · JAMA · doi:10.1001/jama.271.3.204 · Cited by 187
Umbricht, D., Pollack, S. Z., & Kane, J. (1994) · PubMed · Cited by 179
Basile, V. S., Özdemir, V, Masellis, M., Walker, M. L., Meltzer, H. Y., Lieberman, J. A., Potkin, S. G., Alva, G., Kalow, W., Macciardi, F. M., et al. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000736 · Cited by 168
Self-citationDIFFERENTIATION OF TWO GENETICALLY SPECIFIC TYPES OF DEPRESSION BY THE RESPONSE TO ANTI-DEPRESSANTS
Pare, C. M. B., Rees, L., & Sainsbury, M. J. (1962) · The Lancet · doi:10.1016/s0140-6736(62)91019-x · Cited by 165
Turecki, G., Grof, P., Grof, E., D'Souza, V, Lebuis, L., Marineau, C., Cavazzoni, P., Duffy, A., Bétard, C., Zvolský, P., et al. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000888 · Cited by 164
Basile, V (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00114-6 · Cited by 164
Serretti, A., Zanardi, R., Rossini, D., Cusin, C., Lilli, R., & Smeraldi, E. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000876 · Cited by 162
Ethnicity and Treatment Response in Schizophrenia: A Comparison of 3 Ethnic Groups
Emsley, R. A., Roberts, M. C., Rataemane, S., Pretorius, J., Oosthuizen, P. P., Turner, J., Niehaus, D. J. H., Keyter, N., & Stein, D. J. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0103 · Cited by 162
Lithium response and genetics of affective disorders
Grof, P., Alda, M., Gror, E., Zvolsky, P., & Walsh, M. (1994) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)90066-3 · Cited by 161
Mundo, E., Walker, M., Cate, T., Macciardi, F., & Kennedy, J. L. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.539 · Cited by 161
Self-citationTardive dyskinesia: pathophysiology and animal models.
Casey, D. E. (2000) · PubMed · Cited by 156
Pharmacologic treatment of schizophrenia
Kane, J. M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00059-1 · Cited by 156
Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees
Franchini, L., Serretti, A., Gasperini, M., & Smeraldi, E. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)00004-1 · Cited by 156
Sindrup, S. H., Brøsen, K., & Gram, L. F. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.24 · Cited by 156
Segman, R. H., Neeman, T., Heresco‐Levy, U., Finkel, B., Karagichev, L., Schlafman, M., Dorevitch, A., Yakir, A., Lerner, A., Shelevoy, A., et al. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000511 · Cited by 153
Shaikh, S., Collier, D. A., Sham, P. C., Ball, D., Aitchison, K. J., Vallada, H., Kerwin, R. W., Smith, I., & Gill, M. (1996) · Human Genetics · doi:10.1007/bf02346178 · Cited by 150
Plasma catecholamine metabolites and early response to haloperidol.
Mb, B., Swigar, M. E., JATLOW, P. I., et al. (1984) · PubMed · Cited by 146
Association of Risperidone Treatment Response With a Polymorphism in the 5-HT2A Receptor Gene
Lane, H., Chang, Y., Chiu, C., Chen, M., Hsieh, M.-H., & Chang, W. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.9.1593 · Cited by 144
Alfaro, C. L., Lam, Y. W. F., Simpson, J., & Ereshefsky, L. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/009127000004000108 · Cited by 142
Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram
Brøsen, K., & Naranjo, C. A. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00101-8 · Cited by 140
Molecular genetics of bipolar disorder
Craddock, N. J., & Jones, I. R. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.41.s128 · Cited by 140
Schäfer, M., Rujescu, D., Giegling, I., Guntermann, A., Erfurth, A., Bondy, B., & Möller, H. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.5.802 · Cited by 138
The mechanism of lithium action: state of the art, ten years later
Shaldubina, A., Agam, G., & Belmaker, R. H. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00154-3 · Cited by 135
−759C/T genetic variation of 5HT2C receptor and clozapine-induced weight gain
Tsai, S., Hong, C., Yu, Y. W. ‐., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11705-3 · Cited by 131
Malhotra, A. K., Goldman, D. A., Ozaki, N., et al. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.8.1092 · Cited by 129
Self-citationTherapeutic Drug Monitoring of Antidepressants: Cost Implications and Relevance to Clinical Practice
Burke, M. J., & Preskorn, S. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937020-00004 · Cited by 128
Tryptophan hydroxylase gene associated with paroxetine antidepressant activity
Serretti, A., Zanardi, R., Cusin, C., Rossini, D., Lorenzi, C., & Smeraldi, E. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00113-4 · Cited by 127
Serotonin-6 receptor variant (C267T) and clinical response to clozapine
Yu, Y. W. ‐., Tsai, S., Lin, C., Hsu, C., Yang, K., & Hong, C. (1999) · Neuroreport · doi:10.1097/00001756-199904260-00014 · Cited by 126
Serotonin transporter gene associated with lithium prophylaxis in mood disorders
Serretti, A., Lilli, R., Mandelli, L., Lorenzi, C., & Smeraldi, E. (2001) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500006 · Cited by 121
Alderman, J. A., Preskorn, S., Greenblatt, D. J., Harrison, W. M., Penenberg, D. N., Allison, J., & Chung, M. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199708000-00008 · Cited by 121
Efficacy and side-effects of clozapine not associated with variation in the 5-HT2C receptor
Rietschel, M., Naber, D., Fimmers, R., et al. (1997) · Neuroreport · doi:10.1097/00001756-199705260-00040 · Cited by 119
Pharmacogenetic response to antidepressants in a multicase family with affective disorder
O’Reilly, R. L., Bogue, L., & Singh, S. M. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90642-4 · Cited by 116
Allelic Variation in the D4 Dopamine Receptor (DRD4) Gene Does Not Predict Response to Clozapine
Rao, P. A. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950110072009 · Cited by 112
Genetic variation of the 5-HT2A receptor and response to clozapine
Nöthen, M. M., Rietschel, M., Erdmann, J., Oberländer, H., Möller, H., Naber, D., Propping, P., Burnet, P. W. J., & Harrison, P. J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92756-5 · Cited by 111
Cusin, C., Serretti, A., Zanardi, R., Lattuada, E., Rossini, D., Lilli, R., Lorenzi, C., & Smeraldi, E. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002711 · Cited by 110
Time to clozapine response in a standardized trial
Conley, R. R., Carpenter, W. T., & Tamminga, C. A. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.9.1243 · Cited by 106
−759C/genetic variation of 5HT2C receptor and clozapine-induced weight gain
Basile, V. S., Masellis, M., Luca, V. D., Meltzer, H. Y., & Kennedy, J. L. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11706-5 · Cited by 105
Self-citationBenefits and pitfalls encountered in psychiatric genetic association studies
Malhotra, A. K., & Goldman, D. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00365-5 · Cited by 104
Self-citationPare, C. M. B., & Mack, J. W. (1971) · Journal of Medical Genetics · doi:10.1136/jmg.8.3.306 · Cited by 104
Rietschel, M., Naber, D., Oberländer, H., Holzbach, R., Fimmers, R., Eggermann, K., Möller, H. J., Propping, P., & Nöthen, M. M. (1996) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00090-5 · Cited by 103
Suzuki, A., Mihara, K., Kondo, T., Tanaka, O., Nagashima, U., Otani, K., & Kaneko, S. (2000) · Pharmacogenetics · doi:10.1097/00008571-200006000-00007 · Cited by 99
Chen, C.-H., Wei, F., Koong, F., & Hsiao, K. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00543-4 · Cited by 99
Effect of the CYP2D6*10 genotype on venlafaxine pharmacokinetics in healthy adult volunteers
Fukuda, T., Yamamoto, I., Nishida, Y., Zhou, Q., Ohno, M., Takada, K., & Azuma, J. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00913.x · Cited by 98
Davis, R., & Faulds, D. M. (1996) · Drugs · doi:10.2165/00003495-199652050-00007 · Cited by 93
Yue, Q., Zhong, Z., Tybring, G., Dalén, P., Dahl, M., Bertilsson, L., & Sjöqvist, F. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90069-8 · Cited by 91
Steeir, V. M., vlie, R. L., Osher, Y., Belmaker, R. H., Berle, J. ?., & Gulbrandsen, A.-K. (1998) · Pharmacogenetics · doi:10.1097/00008571-199806000-00008 · Cited by 91
Masellis, M., Basile, V. S., Meltzer, H. Y., Lieberman, J. A., Sevy, S. M., Goldman, D. A., Hamblin, M. W., Macciardi, F. M., & Kennedy, J. L. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00016-5 · Cited by 89
Self-citationTsai, S., Hong, C., Yu, Y. W. ‐., Lin, C., Song, H., Lai, H., & Yang, K. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00170-x · Cited by 75
Kohn, Y., Ebstein, R. P., Heresco‐Levy, U., Shapira, B., Nemanov, L., Gritsenko, I., Avnon, M., & Lerer, B. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(96)00380-x · Cited by 74
Physiological Genomics of Antidepressant Targets: Keeping the Periphery in Mind
Blakely, R. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08319.2001 · Cited by 71
HapMap Launched With Pledges of $100 Million
Couzin, J. (2002) · Science · doi:10.1126/science.298.5595.941a · Cited by 70
Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders
Serretti, A., Lorenzi, C., Lilli, R., & Smeraldi, E. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(00)00004-2 · Cited by 69
Serotonin function and treatment response to clozapine in schizophrenic patients
Kahn, R. S., Davidson, M., Siever, L. J., Gabriel, S. M., Apter, S. H., & Davis, K. L. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.9.1337 · Cited by 68
Monozygotic twins concordant for response to clozapine
Vojvoda, D., Grimmell, K., Sernyak, M. J., & Mazure, C. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91594-9 · Cited by 68
Suzuki, A., Kondo, T., Mihara, K., Yasui‐Furukori, N., Ishida, M., Furukori, H., Kaneko, S., Inoue, Y., & Otani, K. (2001) · Pharmacogenetics · doi:10.1097/00008571-200108000-00009 · Cited by 68
Serretti, A., Lilli, R., Lorenzi, C., Franchini, L., Bella, D. D., Catalano, M., & Smeraldi, E. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00056-6 · Cited by 66
Schulze, T. G., Schumacher, J. H., Müller, D. J., Krauß, H., Alfter, D., Maroldt, A., Ahle, G., Maroldt, A., y Fernández, A. N., Weber, T., et al. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1472 · Cited by 66
Shaikh, S., Collier, D. A., Sham, P. C., Pilowsky, L. S., Sharma, T., Lin, L.-Y., Crocq, M. A., Gill, M., & Kerwin, R. W. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320600611 · Cited by 65
The serotonin transporter and clozapine response
Arranz, M. J., Bolonna, A. A., Munro, J., et al. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000652 · Cited by 64
Hori, H., Ohmori, O., Shinkai, T., Kojima, H., & Nakamura, J. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.10045 · Cited by 64
Antidepressants and drug‐metabolizing enzymes — expert group report
Meyer, U., Amrein, R., Balant, L. P., et al. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb09805.x · Cited by 64
Yoon, Y. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.106128 · Cited by 61
Murphy, G. M., Pollock, B. G., Kirshner, M. A., Pascoe, N., Cheuk, W., Mulsant, B. H., & Reynolds, C. F. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00289-5 · Cited by 57
Self-citationSerretti, A., Zanardi, R., Cusin, C., Rossini, D., Lilli, R., Lorenzi, C., Lattuada, E., & Smeraldi, E. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00324-9 · Cited by 55
Dopamine receptor D3 gene and response to lithium prophylaxis in mood disorders
Serretti, A., Lilli, R., Lorenzi, C., Franchini, L., & Smeraldi, E. (1998) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145798001230 · Cited by 50
Preskorn, S., & Magnus, R. D. (1994) · PubMed · Cited by 49
Xu, K., Liu, X. H., Nagarajan, S., Gu, X., & Goldman, D. A. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10374 · Cited by 49
Olanzapine: concordant response in monozygotic twins with schizophrenia
Mata, I. F., Madoz, V., Arranz, M. J., Sham, P. C., & Murray, R. M. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.1.86 · Cited by 44
Fatality Associated With Combined Fluoxetine-Amitriptyline Therapy
Baker, B. (1997) · JAMA · doi:10.1001/jama.1997.03540450038031 · Cited by 38
Özdemir, V., Naranjo, C. A., Shulman, R. W., Herrmann, N., Sellers, E. M., Reed, K. L., & KALOW, W. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199806000-00004 · Cited by 26
Braun, T. G., & Ewald, H. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000600 · Cited by 23
Case-control association studies in complex traits–the end of an era?
Paterson, A. D. (1997) · Molecular Psychiatry · doi:10.1038/sj.mp.4000278 · Cited by 19
Effect of Nortriptyline and Paroxetine on CYP2D6 Activity in Depressed Elderly Patients
Solai, L. K., Pollock, B. G., Mulsant, B. H., Frye, R. F., Miller, M. D., Sweet, R. A., Kirshner, M., Sorisio, D. A., Begley, A. E., & Reynolds, C. F. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200210000-00007 · Cited by 19
原, 暁. (2001) · Medical Entomology and Zoology · Cited by 19
Özdemir, V., Masellis, M., Basile, V. S., KALOW, W., Meltzer, H. Y., Lieberman, J. A., & Kennedy, J. L. (1999) · CNS Spectrums · doi:10.1017/s109285290001186x · Cited by 18
Self-citationPsychiatric Pharmacogenetics A Developing Science
Berrettini, W. H. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00377-3 · Cited by 9
Cited by
Positive Psychology in Clinical Practice
Lee Duckworth, A., Steen, T. A., & Seligman, M. E. P. (2005) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.1.102803.144154 · Cited by 1,095
The genetics of depression: A review
Levinson, D. F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.024 · Cited by 855
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Loss-of-Function Mutation in Tryptophan Hydroxylase-2 Identified in Unipolar Major Depression
Zhang, X., Gainetdinov, R. R., Beaulieu, J.-M., Sotnikova, T. D., Burch, L. H., Williams, R. B., Schwartz, D. A., Krishnan, K. R. R., & Caron, M. G. (2005) · Neuron · doi:10.1016/j.neuron.2004.12.014 · Cited by 473
McMahon, F. J., Buervenich, S., Charney, D., Lipsky, R., Rush, A. J., Wilson, A. F., Sorant, A. J. M., Papanicolaou, G. J., Laje, G., Fava, M., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/503820 · Cited by 474
Metadata
- Authors
- Malhotra, A. K., Murphy, G. M., & Kennedy, J. L.
- Venue
- American Journal of Psychiatry
- Published
- 2004-05-01
- Volume
- 161
- Issue
- 5
- Pages
- 780-796
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2136748552
- Cited by
- 300
- References
- 138
- FWCI
- 25.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.